EUVIMEDEUVIMED entdecken
Crossref

MiR‐222‐3p suppresses C2C12 myoblast proliferation and differentiation via the inhibition of IRS‐1/PI3K/Akt pathway

Xiaofang Wei, Juan Wang, Yaqin Sun, Tong Zhao, Xiaomao Luo, Jiayin Lu, Wei Hou, Xiuju Yu, Linli Xue, Yi Yan, Haidong Wang iD

Journal of Cellular Biochemistry · 2023

DOI: 10.1002/jcb.30453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2023. Verfasst von Xiaofang Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, Shanxi, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous studies have revealed the profound impact of microRNAs on regulating skeletal muscle development and regeneration. However, the biological function and regulation mechanism of miR‐222‐3p in skeletal muscle remains largely unknown. In this study, miR‐222‐3p was found to be abundantly expressed in the impaired skeletal muscles, indicating that it might have function in the development and regeneration process of the skeletal muscle. MiR‐222‐3p overexpression impeded C2C12 myoblast proliferation and myogenic differentiation, whereas inhibition of miR‐222‐3p got the opposite results. The dual‐luciferase reporter assay showed that insulin receptor substrate‐1 (IRS‐1) was the target gene of miR‐222‐3p. We next found that knockdown of IRS‐1 could obviously suppress C2C12 myoblast proliferation and differentiation. Additionally, miR‐222‐3p‐induced repression of myoblast proliferation and differentiation was verified to be associated with a decrease in phosphoinositide 3‐kinase (PI3K)‐Akt signaling. Overall, we demonstrated that miR‐222‐3p inhibited C2C12 cells myogenesis via IRS‐1/PI3K/Akt pathway. Therefore, miR‐222‐3p may be used as a therapeutic target for alleviating muscle loss caused by inherited and nonhereditary diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProto-Oncogene Proteins c-aktAnimalsMiceCell DifferentiationCell ProliferationInsulin Receptor Substrate ProteinsMuscle DevelopmentMyoblastsPhosphatidylinositol 3-KinasePhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

C2C12 cellsIRS-1/PI3K/Akt pathwaydifferentiationmiR-222-3pmyogenesisproliferation

Substanzen

Insulin Receptor Substrate ProteinsMicroRNAsPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktIrs1 protein, mouse

Autor:innen und Institutionen

  • College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, Shanxi, P.R. China.
  • Department of Nephrology, Shanghai General Hosptial, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.

ORCID-Profile: Haidong Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wei, X., Wang, J., Sun, Y., Zhao, T., Luo, X., Lu, J., Hou, W., Yu, X., Xue, L., Yan, Y., & Wang, H. (2023). MiR‐222‐3p suppresses C2C12 myoblast proliferation and differentiation via the inhibition of IRS‐1/PI3K/Akt pathway. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30453

Vancouver

Wei X, Wang J, Sun Y, Zhao T, Luo X, Lu J, et al. MiR‐222‐3p suppresses C2C12 myoblast proliferation and differentiation via the inhibition of IRS‐1/PI3K/Akt pathway. Journal of Cellular Biochemistry. 2023. doi:10.1002/jcb.30453

BibTeX
@article{Wei2023,
  author = {Wei, Xiaofang and Wang, Juan and Sun, Yaqin and Zhao, Tong and Luo, Xiaomao and Lu, Jiayin and Hou, Wei and Yu, Xiuju and Xue, Linli and Yan, Yi and Wang, Haidong},
  title = {MiR‐222‐3p suppresses C2C12 myoblast proliferation and differentiation via the inhibition of IRS‐1/PI3K/Akt pathway},
  journal = {Journal of Cellular Biochemistry},
  year = {2023},
  doi = {10.1002/jcb.30453}
}
Kostenlos starten →